These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
428 related articles for article (PubMed ID: 33895475)
1. Potential SARS-CoV-2 vaccines: Concept, progress, and challenges. Hosseini SA; Zahedipour F; Mirzaei H; Kazemi Oskuee R Int Immunopharmacol; 2021 Aug; 97():107622. PubMed ID: 33895475 [TBL] [Abstract][Full Text] [Related]
2. Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development? Lu L; Zhang H; Zhan M; Jiang J; Yin H; Dauphars DJ; Li SY; Li Y; He YW Sci China Life Sci; 2020 Dec; 63(12):1833-1849. PubMed ID: 33355886 [TBL] [Abstract][Full Text] [Related]
3. COVID-19 - Recent advancements in identifying novel vaccine candidates and current status of upcoming SARS-CoV-2 vaccines. Iqbal Yatoo M; Hamid Z; Parray OR; Wani AH; Ul Haq A; Saxena A; Patel SK; Pathak M; Tiwari R; Malik YS; Sah R; Rabaan AA; Rodriguez Morales AJ; Dhama K Hum Vaccin Immunother; 2020 Dec; 16(12):2891-2904. PubMed ID: 32703064 [TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments. Canedo-Marroquín G; Saavedra F; Andrade CA; Berrios RV; Rodríguez-Guilarte L; Opazo MC; Riedel CA; Kalergis AM Front Immunol; 2020; 11():569760. PubMed ID: 33362758 [TBL] [Abstract][Full Text] [Related]
5. COVID-19 Vaccine: A comprehensive status report. Kaur SP; Gupta V Virus Res; 2020 Oct; 288():198114. PubMed ID: 32800805 [TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials. Lim HX; Arip M; Yahaya AAA; Jazayeri SD; Poppema S; Poh CL Front Biosci (Landmark Ed); 2021 Nov; 26(11):1286-1304. PubMed ID: 34856768 [TBL] [Abstract][Full Text] [Related]
7. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity. Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P Cells; 2021 Oct; 10(11):. PubMed ID: 34831172 [TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2: Current trends in emerging variants, pathogenesis, immune responses, potential therapeutic, and vaccine development strategies. Salimi-Jeda A; Abbassi S; Mousavizadeh A; Esghaie M; Bokharaei-Salim F; Jeddi F; Shafaati M; Abdoli A Int Immunopharmacol; 2021 Dec; 101(Pt A):108232. PubMed ID: 34673335 [TBL] [Abstract][Full Text] [Related]
10. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting. Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J Front Immunol; 2021; 12():802858. PubMed ID: 35003131 [TBL] [Abstract][Full Text] [Related]
11. On the road to ending the COVID-19 pandemic: Are we there yet? Case JB; Winkler ES; Errico JM; Diamond MS Virology; 2021 May; 557():70-85. PubMed ID: 33676349 [TBL] [Abstract][Full Text] [Related]
12. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7. Wang P; Nair MS; Liu L; Iketani S; Luo Y; Guo Y; Wang M; Yu J; Zhang B; Kwong PD; Graham BS; Mascola JR; Chang JY; Yin MT; Sobieszczyk M; Kyratsous CA; Shapiro L; Sheng Z; Huang Y; Ho DD Nature; 2021 May; 593(7857):130-135. PubMed ID: 33684923 [TBL] [Abstract][Full Text] [Related]
15. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies. Frederiksen LSF; Zhang Y; Foged C; Thakur A Front Immunol; 2020; 11():1817. PubMed ID: 32793245 [TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2: Unique Challenges of the Virus and Vaccines. Mahmoodpoor A; Sanaie S; Samadi P; Yousefi M; Nader ND Immunol Invest; 2021 Oct; 50(7):802-809. PubMed ID: 34109900 [TBL] [Abstract][Full Text] [Related]
17. Interpretative immune targets and contemporary position for vaccine development against SARS-CoV-2: A systematic review. Chauhan N; Soni S; Gupta A; Aslam M; Jain U J Med Virol; 2021 Apr; 93(4):1967-1982. PubMed ID: 33270225 [TBL] [Abstract][Full Text] [Related]
18. COVID-19 vaccines: what do we know so far? Dhillon P; Altmann D; Male V FEBS J; 2021 Sep; 288(17):4996-5009. PubMed ID: 34288409 [TBL] [Abstract][Full Text] [Related]